Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,76 USD | -1,12% | -5,88% | -88,04% |
11/04 | AMYLYX PHARMACEUTICALS, INC. : Baird is Neutraal gestemd over aandeel | ZM |
10/04 | Transcript : Amylyx Pharmaceuticals, Inc. - Special Call |
Omzet 2024 * | 102 mln. 95,19 mln. | Omzet 2025 * | 167K 156K | Marktkapitalisatie | 120 mln. 112 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -105 mln. -98,2 mln. | Nettowinst (verlies) 2025 * | -84 mln. -78,56 mln. | EV/omzet 2024 * | 0,67 x |
Nettoliquiditeiten 2024 * | 51,6 mln. 48,26 mln. | Nettoliquiditeiten 2025 * | 168 mln. 157 mln. | EV/omzet 2025 * | -292 x |
K/w-verhouding 2024 * |
-1,15
x | K/w-verhouding 2025 * |
-1,49
x | Werknemers | 384 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 82,4% |
Recentste transcriptie over Amylyx Pharmaceuticals, Inc.
1 dag | -1,12% | ||
1 week | -5,88% | ||
Lopende maand | -38,03% | ||
1 maand | -38,89% | ||
3 maanden | -88,56% | ||
6 maanden | -88,82% | ||
Lopend jaar | -88,04% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Justin Klee
FOU | Founder | 34 | 01-01-13 |
Josh Cohen
FOU | Founder | 33 | 01-01-13 |
Jim Frates
DFI | Director of Finance/CFO | 56 | 01-01-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
George Milne
CHM | Chairman | 80 | 01-01-15 |
Kari Firestone
BRD | Director/Board Member | - | 16-03-23 |
Paul R. Fonteyne
BRD | Director/Board Member | 63 | 29-03-21 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.14% | 0 M€ | 0,00% | - | |
0.09% | 237 M€ | +2,89% | - | |
0.04% | 2 M€ | -.--% | ||
0.02% | 9 M€ | +6,26% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 1,76 | -1,12% | 5 218 046 |
25-04-24 | 1,78 | -5,32% | 2 479 181 |
24-04-24 | 1,88 | -3,59% | 1 741 628 |
23-04-24 | 1,95 | -1,52% | 1 471 449 |
22-04-24 | 1,98 | +5,88% | 1 555 644 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-88,04% | 120 mln. | |
-4,66% | 86,13 mld. | |
+1,32% | 39,82 mld. | |
-19,27% | 30,42 mld. | |
+57,86% | 25,23 mld. | |
-16,09% | 15,36 mld. | |
-9,14% | 11,95 mld. | |
-17,69% | 11,6 mld. | |
-43,00% | 11,51 mld. | |
+5,24% | 8,71 mld. |